Similar articles

• Natalizumab for Crohn's Disease: Down but Not Out.

  Scott FI, Osterman MT. Scott FI, et al. Clin Gastroenterol Hepatol. 2015 Nov;13(11):1926-8. doi: 10.1016/j.cgh.2015.07.020. Epub 2015 Jul 18. Clin Gastroenterol Hepatol. 2015. PMID: 26196443 No abstract available.
• Failure to Account for Immortal Person Time Likely Accounts for the Apparent Reduction in Surgery Among Natalizumab Users.

  Targownik LE. Targownik LE. Clin Gastroenterol Hepatol. 2016 May;14(5):776. doi: 10.1016/j.cgh.2015.11.008. Epub 2015 Nov 22. Clin Gastroenterol Hepatol. 2016. PMID: 26614877 No abstract available.
• Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy.

  Bellaguarda E, Keyashian K, Pekow J, Rubin DT, Cohen RD, Sakuraba A. Bellaguarda E, et al. Clin Gastroenterol Hepatol. 2015 Nov;13(11):1919-25. doi: 10.1016/j.cgh.2015.05.022. Epub 2015 May 19. Clin Gastroenterol Hepatol. 2015. PMID: 26001336 Free PMC article.
• The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy.

  Reuwer AQ, Heron M, van der Dussen D, Schneider-Hohendorf T, Murk JL. Reuwer AQ, et al. Acta Neurol Scand. 2017 Nov;136 Suppl 201:37-44. doi: 10.1111/ane.12840. Acta Neurol Scand. 2017. PMID: 29068484 Review.
• Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?--The JC Virus Story in multiple sclerosis.

  Achiron A, Miron S, Shoenfeld Y. Achiron A, et al. Isr Med Assoc J. 2005 May;7(5):283-5. Isr Med Assoc J. 2005. PMID: 15909458 Review. No abstract available.